RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
We have several comments regarding the letters about our study.1 First, Gerard Visser and Gian Carlo DiRenzo state that if corticosteroids are given appropriately they can reduce perinatal morbidity and mortality, whereas inappropriate use is likely to be harmful. However, the evidence showing that corticosteroids reduce neonatal morbidity and mortality are from studies done in hospitals in high-income and middle-income countries with good newborn care. By contrast, our antenatal corticosteroid trial (ACT)1 was done in low-income and middle-income countries, evidence showed no benefit with use of this drug.